Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Farmers Insurance
Harvard Business School
Cantor Fitzgerald

Generated: August 23, 2017

DrugPatentWatch Database Preview

Estrogens, esterified - Generic Drug Details

« Back to Dashboard

What are the generic sources for estrogens, esterified and what is the scope of estrogens, esterified patent protection?

Estrogens, esterified
is the generic ingredient in six branded drugs marketed by Sandoz, Pvt Form, Solvay, Roche Palo, Monarch Pharms, and Bristol Myers Squibb, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for estrogens, esterified. Three suppliers are listed for this compound.

Summary for Generic Name: estrogens, esterified

Drug Master File Entries: see list3
Suppliers / Packagers: see list3
Bulk Api Vendors: see list64
Clinical Trials: see list187
Patent Applications: see list33,517
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:estrogens, esterified at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pvt Form
estrogens, esterified
TABLET;ORAL085076-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Monarch Pharms
estrogens, esterified
TABLET;ORAL084948-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Pvt Form
estrogens, esterified
TABLET;ORAL085907-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
estrogens, esterified
TABLET;ORAL083266-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
estrogens, esterified
TABLET;ORAL083266-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus